SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-075405
Filing Date
2023-09-08
Accepted
2023-09-08 16:21:21
Documents
14
Period of Report
2023-09-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea184948-8k425_lucyscien.htm   iXBRL 8-K 31334
2 STOCK PURCHASE AGREEMENT, BY AND AMONG LUCY SCIENTIFIC DISCOVERY, INC., HIGHTIME ea184948ex2-1_lucyscien.htm EX-2.1 200806
3 PRESS RELEASE OF LUCY SCIENTIFIC DISCOVERY, INC., DATED SEPTEMBER 7, 2023 ea184948ex99-1_lucyscien.htm EX-99.1 16107
  Complete submission text file 0001213900-23-075405.txt   474364

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE lsdi-20230906.xsd EX-101.SCH 3033
5 XBRL LABEL FILE lsdi-20230906_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE lsdi-20230906_pre.xml EX-101.PRE 22371
8 EXTRACTED XBRL INSTANCE DOCUMENT ea184948-8k425_lucyscien_htm.xml XML 3347
Mailing Address 301-1321 BLANSHARD STREET VICTORIA A1 V8W 0B6
Business Address 301-1321 BLANSHARD STREET VICTORIA A1 V8W 0B6 778-410-5195
Lucy Scientific Discovery, Inc. (Filer) CIK: 0001865127 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-41616 | Film No.: 231245559
SIC: 2834 Pharmaceutical Preparations